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Abstract
Background: As a culmination of efforts over the last years, our knowledge of the embryonic origins of the mammalian
frontal and parietal cranial bones is unambiguous. Progenitor cells that subsequently give rise to frontal bone are of neural
crest origin, while parietal bone progenitors arise from paraxial mesoderm. Given the unique qualities of neural crest cells
and the clear delineation of the embryonic origins of the calvarial bones, we sought to determine whether mouse neural
crest derived frontal bone differs in biology from mesoderm derived parietal bone.
Methods: BrdU incorporation, immunoblotting and osteogenic differentiation assays were performed to investigate the
proliferative rate and osteogenic potential of embryonic and postnatal osteoblasts derived from mouse frontal and parietal
bones. Co-culture experiments and treatment with conditioned medium harvested from both types of osteoblasts were
performed to investigate potential interactions between the two different tissue origin osteoblasts. Immunoblotting
techniques were used to investigate the endogenous level of FGF-2 and the activation of three major FGF signaling
pathways. Knockdown of FGF Receptor 1 (FgfR1) was employed to inactivate the FGF signaling.
Results: Our results demonstrated that striking differences in cell proliferation and osteogenic differentiation between the
frontal and parietal bone can be detected already at embryonic stages. The greater proliferation rate, as well as osteogenic
capacity of frontal bone derived osteoblasts, were paralleled by an elevated level of FGF-2 protein synthesis. Moreover, an
enhanced activation of FGF-signaling pathways was observed in frontal bone derived osteoblasts. Finally, the greater
osteogenic potential of frontal derived osteoblasts was dramatically impaired by knocking down FgfR1.
Conclusions: Osteoblasts from mouse neural crest derived frontal bone displayed a greater proliferative and osteogenic
potential and endogenous enhanced activation of FGF signaling compared to osteoblasts from mesoderm derived parietal
bone. FGF signaling plays a key role in determining biological differences between the two types of osteoblasts.
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Introduction
Bones of the cranial vault form through the process of
intramembranous ossification [1]. Calvarial bones arise from two
embryonic tissue origins, namely the neural crest and mesoderm.
The distinct contributions of each tissue to the skull have been well
established by combining mice with a Wnt1-Cre construct and a
conditional reporter gene, R26R [2,3]. These studies have defined
the pattern of cranial neural crest cell migration in mouse embryos
and demonstrated that the frontal bone is of neural crest origin,
whereas the parietal bone is of mesoderm origin. The neural crest
(NC) is a population of cells unique to the vertebrate embryo
[4,5,6]. NC cell (NCC) progenitors originate from the neural plate
border, and migrate into the periphery to contribute to multiple
lineages [7,8,9]. In all vertebrates a large part of the skull and the
entire facial skeleton are derived from cephalic NCC.
Development of the normal skull vault requires mechanisms to
ensure that both its morphology and its rate of growth are
precisely matched to those of the developing brain. This precise
relationship suggests that there are important tissue interactions
between the brain and the skeletogenic membranes also involving
the mesenchymal layers between them (the developing meninges).
A multitude of signaling molecules, as well as their respective
receptors and downstream transcriptional factors, act in concert to
regulate bone development [10,11,12]. In particular, fibroblast
growth factor (FGF) signaling has gained much attention for its
major role in skeletogenesis, including calvarial osteogenesis
[13,14,15,16]. FGF signaling is known to play a critical role in
regulating proliferation and differentiation of osteoblasts and
osteogenic precursors [17,18,19,20].
Binding of FGF ligands to their receptors leads to activation of
three different intracellular pathways: mitogen-activated protein-
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C (PKC) and phosphoinositide 3-kinases (PI3K) [21,22,23]. These
pathways can mediate effects of FGF-signaling on osteoblast gene
regulation [24,25,26].
Our previous in vitro and in vivo studies demonstrated that
differences between the neural crest derived frontal and mesoder-
mal derived parietal bone of both, juvenile and adult mice, exist
[27]. Of interest, this study revealed that neural crest derived
frontal bone has superior potential for osteogenic differentiation
and healing compared to mesodermal derived parietal bone.
Moreover, an enhanced activation of endogenous canonical Wnt
signaling in frontal bone, relatively to parietal bone was identified,
both in vitro and in vivo [27].
Furthermore, a detailed comparative gene expression profile of
FGF ligands and their receptors carried out on frontal and parietal
bones revealed a differential expression pattern of the major FGF
osteogenic genes and their receptors between the neural
crestderived frontal bone and the paraxial mesoderm derived
parietal bone [28]. Particularly, the expression of ligands such Fgf-
2, Fgf-9 and Fgf-18 was found to be significantly upregulated in
frontal bone in embryonic day 17.5 (E17.5), postnatal day 1 and
60 mice. Frontal bone also elaborated higher levels of Fgf receptors
FgfR1, FgfR2 and FgfR3 transcripts versus parietal bone. Thus,
these observations strongly suggested that neural crest-derived
frontal bone might be a highly activated FGF-signaling domain
compared to parietal bone. Indeed, determining the role of FGF
signaling in imparting superior osteogenic/regenerative potential
on calvarial tissue is of paramount importance.
Therefore, our previous studies prompted us to further
investigate on the biological properties of neural crest derived
frontal and mesodermal derived parietal bones.
In the current study we analyzed the cell proliferation and
osteogenic potential properties of embryonic E17.5 E18.5 and
early postnatal day 1 (P1) osteoblasts derived from frontal (FOb)
and parietal (POb) bones. In addition, we characterized the
endogenous activation of the three major FGF signaling pathways:
MAPK, PI3K, PKC, and unveiled higher activation of all three
FGF signaling pathways in FOb cells compared to POb cells.
Furthemore, by knocking down the Fgf Receptor1(FgfR1) we have
highlighted the crucial role played by FGF signaling in conferring
greater osteogenic potential to neural crest derived frontal
osteoblasts.
Materials and Methods
Animals
All experiments using animals were performed in accordance
with Stanford University Animal Care and Use Committee
guidelines with protocol ID #8397. CD-1 wild-type mice were
purchased from Charles River Laboratories Inc., Wilmington,
MA. Animals were housed in light- and temperature-controlled
rooms and were given food and water ad libitum.
Tissue Harvesting and Primary Cell Culture
Neural crest derived frontal osteoblasts (FOb) and mesoderm
derived parietal osteoblasts (POb) were harvested from skulls of
embryonic day 17.5 (E17.5), 18.5 (E18.5) and postnatal day 1 (P1)
respectively. The periosteum and dura mater were carefully
stripped off from the skull. The peripheral suture complexes of
each frontal or parietal bone were also carefully removed. Frontal
and parietal bones were minced separately into small chips less
than 1 mm before digestion. Embryonic skulls (E17.5 and E18.5)
were digested with 0.1% Collagenase A (Roche Diagnostics,
Indianapolis, IN, USA) in serum free a-MEM (alpha minimum
essential medium, Gibco Life Technologies and Invitrogen
Corporation, Carlsbad, CA) for 30 minutes at 37uC in a shaking
water bath. P1 skulls were digested with 0.2% Dispase II and 0.1%
Collagenase A (Roche Diagnostics, Indianapolis, IN, USA) in
serum-free medium. The digestion was carried out 6 times, each
10 minutes. The first 2 digestions were discarded. The later four
digestions were pooled together. All digestions were neutralized
with an equal volume of a-MEM supplemented with 10% FCS
(fetal calf serum, Gemini Bioproducts, Woodland, CA), 100 IU/ml
penicillin and streptomycin (Invitrogen Corporation), pelleted, and
resuspended in the culture medium. Both FOb and POb cells were
plated in 100 mm tissue culture dishes (Corning Incorporated, San
Mateo, CA) and incubated at 37uC with continuous supplement of
5% CO2. The medium was changed every other day. Only
passage 0 and 1 cells were used for all experiments.
FOb and POb cell co-cultures
Co-culture experiments were carried out using 6-transwell
chamber plates (Corning Costar, Cambridge, MA). FOb or POb
were plated onto either on the top chambers (inserts) (4610
4/
insert for 6 well plates & 2610
4/insert for 12 well plates) or the
bottom chambers (8610
4/well for 6 well plates & 4610
4/well for
12 well plates). The inserts had a pore size of 0.4 mm. This pore
size would allow the diffusion of soluble factors between the two
cell populations, but would prevent the transfer of any cells or
organelles. The two cell populations were cultured separately
overnight and then were combined with regular culture medium:
a-MEM supplemented with 10% FCS, 100 IU/ml penicillin and
100 IU/ml streptomycin. For cell proliferation assay, the
combined two cell populations of the 12 well plates were cultured
with serum free a-MEM for 12 or 24 hours and the cells were
labeled with BrdU for 12 hours and detected. For cell differen-
tiation assay, cells were incubated with the osteogenic differenti-
ation medium (ODM), a-MEM supplemented with 10 mM
glycerol b-phosphate, 0.25 mM ascorbic acid, (Sigma-Aldrich,
MO, USA), 1% penicillin, streptomycin and 3% FCS. The bottom
chambers were stained for alkaline phosphatase at day 7 of
differentiation assay using the Alkaline phosphatase Kit (Sigma-
Aldrich, MO, USA) according to the manufacturer’s instructions.
Alkaline phosphatase enzymatic activity was determined by
biochemical colorimetric assay with Sigma-Aldrich alkaline
phosphatase staining kit (85L-2) as previously described [20].
After three weeks of differentiation cells were stained with Alizarin
red staining, followed by its quantification as previously described
[27,29].
Statistical Analysis
The results are presented as the mean 6 SD of three
independent experiments. Statistical differences between the
means are examined by Student’s test. The comparison for
significant differences in multiple groups was done with ANOVA.
A P value ,0.05 was considered statistically significant.
Osteogenic Differentiation Assays
FOb or POb cells were plated in 6-well-plate (1610
5/well). Upon
sub-confluence, the osteogenic differentiation medium (ODM,
10 mM glycerol b-phosphate, Sigma and 0.25 mM ascorbic acid,
Sigma in a-MEM supplemented with 1% penicillin, streptomycin
and 10% FCS) was applied onto cells. The medium was changed
every other day. The ODM made by frontal osteoblast cell-
conditioned medium (dFCM) or by parietal osteoblast cell-
conditioned medium (dPCM) were supplemented with 3% FCS.
Alkaline phosphatase and Alizarin red staining to assess mineral-
ization of extracellular matrix were performed as above. All
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using Leica DMIL microscope and Leica Microsystems digital
imaging software (Leica Microsystems Wetzlar, Germany).
Procedures for RNA isolation, reverse-transcriptase polymerase
chain reaction (RT-PCR), quantitative real time PCR analysis and
primer sequences were previously described [20,27,29].
Preparation of Cell-Conditioned Media
Cell-conditioned media (CM) were obtained from either FOb or
POb cells. The two conditioned medium are referred as frontal
conditioned medium (FCM) and parietal conditioned medium
(PCM). Briefly, 8610
5 FOb or POb cells (8610
5) were plated in
100 mm plates separately. Upon subconfluence, the cells were
washed three times with sterile PBS prior to addition of serum free
medium. After culture in serum free medium for 24 hours, the
cell-conditioned media were collected and concentrated 10 fold
using Centricon filters (Centricon-3, 3000 NMWL, Millipore
Corporation, MA). Collection and concentration of the media
were carried out at 4uC. The concentrated media were
replenished with fresh a-MEM to the original volumes. The
volumes of the conditioned media were also normalized by cell
numbers so that an equal volume of FCM or PCM was produced
by equal number of FOb or POb cells. All experiments were
performed three times using freshly harvested media.
Cell Proliferation Assays
The growth rate of FOb and POb cells was assessed by BrdU
incorporation assay as well as immunoblotting analysis of
proliferating cellular nuclear antigen (PCNA). For the BrdU
incorporation assay, FOb and POb cells were plated at density of
1500 cells/well, in 96-multiwell culture plates with flat bottoms
(Corning Incorporated, San Mateo, CA). Cells were incubated in
culture medium for 6 hours. Then, cells were washed twice with
sterile PBS and cultured in serum-free a-MEM or FCM and PCM
for 12 or 24 hours. BrdU incorporation was carried out for
12 hours (Roche Diagnostics Corporation, IN) according to the
manufacturer’s instructions. Photometric detection was done with
an ELISA reader at 370 nm wavelength. The background was
subtracted when the resulting data were processed. Each
experiment was run in triplicate. For the growth curve assay,
FOb and POb cells were seeded in 6 well plates in triplicate at
density of 10
5 cells/well. Cells were grown in a-MEM supple-
mented with 1% penicillin, streptomycin and 10% FCS. Cell
counting was performed in triplicate using a hematocytometer at
days 2, 4, 6, 8 and 10. The first day after seeding represents day 0.
For the growth curve with inhibitors cells were plated and cultured
as above. Growth medium was supplemented with 5 mM U-0126,
10 mM LY-294002 and 1 mMG O ¨ -6983. Control cells were
maintained in growth medium containing 0.1%DMSO. Western
blotting analysis of PCNA was performed on cell lysates, using
RIPA Buffer (Sigma Aldrich, US). Total cellular proteins were
extracted from FOb and POb after cultured in serum-free medium
for 24 hours. Proteins were quantified by Bicinchoninic Acid
(BCA) protein assay (Pierce, IL). Fifty micrograms of total cellular
protein were resolved onto 10% Nupage Tris-HCl sodium dodecyl
sulfate (SDS)-PAGE gel (Precast Nupage gel, Invitrogen, Life
Technologies) and transferred onto Immuno-Blot PVDF mem-
branes (Bio-Rad, Hercules CA, USA). Membranes were blocked
with 5% natural nonfat dry milk before probed with anti-PCNA
antibody (FL-261 sc7970, rabbit polyclonal 1:400, Santa Cruz
Biotechnology, CA, USA). A horseradish peroxidase-conjugated
anti-mouse (HRP) 1:8000, (Santa Cruz Biotechnology, CA) was
used as secondary antibody. Immunoblotted products were
visualized by enhanced chemiluminescence substrate (Amersham-
Biosciences, UK). Subsequently, the membranes were stripped of
the antibodies by incubation onto a stripping solution (62.5 mM
Tris-HCl, pH 7.5, 2%SDS, 100 mM b-mercaptoethanol) for 30
minutes at 52uC followed by three washes at RT with 20 mM
Tris, 136 mM NaCl pH 7.6 (TBS). Membranes were blocked with
5% milk and then incubated with a-tubulin antibody (B-7 sc-5286,
mouse monoclonal 1:600, Santa Cruz Biotechnology, CA) to
control for equal loading and transfer of the samples.
Detection of FGF-2 protein in FOb and POb cells
Endogenous FGF-2 was detected by western blot analysis. Cell
lysates were prepared with RIPA buffer and the total proteins were
quantified by BCA assay as mentioned above. Fifty micrograms of
total cellular protein were separated onto 12% Nupage gels Tris-
HCl sodium dodecyl sulfate (SDS)-PAGE, transferred onto
Immuno-Blot PVDF membranes, and blocked with 5% natural
nonfat dry milk as described before. FGF-2 was detected by anti-
FGF-2 antibody (147, SC-79, rabbit polyclonal 1:400, Santa Cruz
Biotechnology, CA, USA) and a horseradish peroxidase-conjugat-
ed anti-rabbit antibody (1:8000, Santa Cruz, Biotechnology, CA,
USA) was used as secondary antibody Densitometry of FGF-2
bands was performed using the ImageJ software program, (NIH,
Bethesda, MA). The density of each FGF-2 bands was normalized
to the loading controls (a-tubulin).
Neutralization of FGF-2 Bioactivity
A polyclonal goat anti-FGF-2 antibody (R&D systems, MN) was
used for FGF-2 neutralization. Serum-free FCM and PCM were
pre-incubated with 1 mg/ml, 2 mg/ml or 4 mg/ml of anti-FGF-2
antibody for 3 hours at 4uC prior to application on FOb or POb
cells. Osteoblast proliferation was determined by BrdU incorpo-
ration assay as described above. Osteoblasts stimulated with
20 ng/ml of rhFGF-2 (hBA-154, Santa Cruz, Biotechnology, CA,
USA) were used as positive controls. Normal irrelevant rabbit IgG
(sc2027, Santa Cruz Biotechnology, CA, USA) was used as
internal control, and serum-free medium as negative control.
Characterization of activation of FGF Signaling Pathways
in FOb and POb cells
The endogenous activation of FGF signaling pathways in FOb
and POb cells was investigated by immunoblotting analysis of
phosphorylated signaling proteins. Subconfluent FOb and POb
cells were washed twice with 1X PBS and starved in serum-free
medium overnight. Then the cells were washed twice with ice-cold
PBS and lysed with cold lysis buffer (50 mmol/L of HEPES,
pH 7.5, 150 mmol/L of NaCl, 1 mmol/of EDTA, 10% glycerol,
1% Triton-X-100, 25 mmol/L of sodium fluoride) containing
1 mmol/L of sodium orthovanadate and Protease Inhibitor
Cocktail (Sigma-Aldrich, St. Louis, MO). Cell lysates were assayed
for protein concentration by BCA assay as described above.
Aliquots (50–100 mg) of cell lysate were electrophoresed on 12%
Tris-HCl sodium dodecyl sulfate (SDS)-PAGE gels (Precast Nupage
gels, Invitrogen, Life technologies) and transferred onto Immobilon-
P membrane (Millipore Corporation, Bedford, MA). Antibodies
against the specific phosphorylated proteins of each signaling
pathway were chosen as follows: anti-phospho-ERK p44/42
(Thr202/Tyr204 rabbit polyclonal antibody 1:1000, Cell Signaling
Technology, Beverly, MA), anti-phospho-Akt (Ser 473 rabbit
monoclonal antibody 1:1000, Cell Signaling Technology, Beverly,
MA), anti-phospho-PKC a/b Thr638/641 rabbit polyclonal
antibody 1:1000, Cell Signaling Technology, Beverly, MA), anti-
phospho-PKC d (Thr505 rabbit polyclonal 1:1000, Cell Signaling
Technology, Beverly, MA), anti-ERK-1/2 (C-14 mouse monoclo-
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CA), anti-Akt (rabbit polyclonal antibody 1:1000, Cell Signaling
Technology, Beverly, MA) and anti-PKC/PKD (rabbit polyclonal
antibody 1:1000, Cell Signaling Technology, Beverly, MA). A
horseradish peroxidase-conjugated anti-rabbit antibody (HRP)
1:8000 was used as secondary antibody. Immunoblotted products
were visualized by enhanced chemiluminescence substrate (Amer-
sham Biosciences, UK). a-tubulin antibody was used to control for
equal loading and transfer of the samples, as mentioned previously.
All bands of the phosphorylated or non-phosphorylated proteins in
the immunoblots were normalized with the loading controls (a-
tubulin) and quantified by densitometry. The statistical significance
in comparison of the 2 type cells were presented by asterisks when P
values were less than 0.05.) The FGF-2 induction and inhibitor
blocking of the three signaling transduction pathways were also
conducted on embryonic E17.5 cells (FOb & POb). 20 ng/ml of
exogenous FGF-2 was used for the induction (rhFGF-2, SantaCruz
Biotechnology). Inhibitors to block the three FGF signaling
pathways) block were used as follows: 10 mM U-0126 to block the
MAPK pathway, 20 mM LY-294002 to block the PI3K pathway,
and 2 mMG O ¨ -6983 to block the PKC pathway (Calbiochem-
Novabiochem. The inhibitors were dissolved in 0.1% DMSO as
vehicle. Briefly, subconfluent cells were starved at in serum-free
mediumovernightandpre-incubated for 30minuteswith one ofthe
three inhibitors before any treatments. The rhFGF-2 induction was
carried out for 30 minutes. To determine the nonspecific
contribution of DMSO to FGF-2 signal inhibition, a separate
group of cells was incubated with 0.1% DMSO alone. A group of
cells without FGF-2inductionwasalsoincubatedwith theinhibitors
for 30 minutes to block the phosphorylation of the endogenous
signalingproteins.Celllysatepreparations,immunoblottinganalysis
and densitometry were performed as described above. All
experiments were performed 3 times with similar results. The
densitometric results of both phosphorylated and non-phosphory-
lated signaling proteins were normalized to the respective loading
control (alpha-tubulin bands).
Transduction of FOb cells with shFgfR lentivirus
Primary E17.5 osteoblasts (passage 0) derived from frontal bone
were transduced with FgfR1 shRNA lentiviral particles (Flg shRNA
sc-29317-V, Santa Cruz Biotechnology) as previously described
[27,29]. A lentivirus shRNA Scramble (sc-108080, Santa Cruz
Biotechnology) was used as negative control. After 24 hours, the
infected cells were split 1:4 and grown in a-MEM supplemented
with 10%FCS and 10 mg/ml Puromicin. Upon puromycin
selection, puromycin positive cells were seeded in 6-well plates at
concentration of 380.000/well and cultured in osteogenic medium
(a-MEM supplemented with 10%FCS, 10 mM b-glycerophosphate
and 100 mg/ml ascorbic acid). To validate the downregulation of
FgfR1, RNA was isolated from cells and reverse transcribed as
previously described [20]. Conditions for PCR analysis and oligos
sequence were previously described [27]. Immunoblotting analysis
was performed on 100 mg of cell lysate using anti-FGFR1 antibody
(Flg C-15/sc-121, dilution 1:200) Alkaline phoshatase enzymatic
activity and Alizarin staining were performed as mentioned above.
Experiments were performed two times with similar results.
Results
Osteogenic potential of neural crest derived frontal
osteoblasts and mesenchymal derived parietal
osteoblasts
To verify whether differences in osteogenic potential of neural
crest derived and mesodermal derived calvarial bones could be
already detect at embryonic stages we performed an osteogenic
differentiation assay on FOb and POb cells harvested from
embryos at day 17.5 and 18.5. P1 FOb and POb cells were used as
reference. Staining for Alkaline phosphates, an early/intermediate
marker of osteogenesis, revealed striking differences between FOb
and POb cells. As illustrated in Figure 1A and B, at day 7 of
differentiation E17.5 and E18.5 FOb cells showed a more intense
alkaline phosphatase staining and enzymatic activity than POb
cells, indeed, resembling differences previously observed between
either juvenile or adult FOb and POb [27]. Alizarin Red staining
and its quantification (Figure 1C and D) revealed even more
striking differences between embryonic FOb and POb cells, larger
bone nodule formation and more robust mineralization of
extracellular matrix could be detected in FOb as compared to
POb (Figure 1C). To further examine the osteogenic potential of
frontal and parietal osteoblasts, the temporal expression of early,
intermediate, and late osteoblast specific markers Runx-2, Alk phos,
and Osteocalcin was determined by quantitative real time RT-PCR
analysis (Figure 1E). This analysis revealed higher expression levels
of all three osteogenic markers in FOb cells as compared to POb
cells. Thus, the above data indicated that indeed, differences in the
osteogenic potential of FOb and POb cells could be already
identified in embryonic tissues.
To further delineate differences between the two types of
osteoblasts we next analyzed their cell proliferation by BrdU
incorporation assay. As shown in Figure 1E, FOb cells displayed
significant higher cell proliferation capabilities compare to POb
cells. The higher proliferation activity of FOb was further
confirmed by western blot analysis of proliferating cellular nuclear
antigen (PCNA) revealing a more intense PCNA bands in FOb
(Figure 1F). The results were normalized to a-tubulin. Each
electrophoresis band was quantified by densitometry, the differ-
ences between the FOb and POb cells were statistically significant
with a *P value less than 0.05.
In addition, a long term growth curve assay performed by cell
counting for 10 days also revealed a greater proliferative activity in
FOb cells as compared to POb cells (Figure 1H).
Interactive effects of neural crest derived frontal
osteoblasts and mesenchymal derived parietal
osteoblasts on cell growth and osteoblast differentiation
To investigate whether FOb and POb influence each other in
their proliferation and osteogenic potential we performed co-
cultures using the two types of cells harvested from E17.5 mice. In
co-cultures, FOb and POb were separated by a micro-porous
membrane with 0.4 mm pores, so that only humeral factors
released in the medium but not cells, could pass through the
membrane. Two different types of co-culture were set up:
heterotypic culture comprising of FOb and POb and homotypic
cultures comprising of FOb/FOb and POb/POb. Each cell type
cultured alone was used as control. Measurement of cell
proliferation by BrdU incorporation clearly indicated that POb
cells proliferated more than control when co-cultured with FOb,
but not when co-cultured with POb cells (Figure 2A). Moreover,
other combinations of co-cultures did not show significant
mitogenic effect. The osteogenic differentiation of FOb and POb
in co-culture was also tested (Figure 2B). After 3 weeks of
differentiation, Alizarin Red staining assay and its quantification
was performed on the osteoblasts in the lower compartment of the
transwell plate. Overall, POb cells differentiated less than FOb
cells. Interestingly, for POb cells, the co-culture with FOb
significantly promoted the osteogenic differentiation. Homotypic
FOb co-cultures did not show prominent effect on differentiation,
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inhibitory effect on FOb differentiation.
Thus, results from the co-culture experiments indicated that
there are humeral factors released in the medium by FOb which
might in a paracrine fashion promote proliferation and/or
osteogenic differentiation of POb. To explore this possibility we
collected conditioned media, from both frontal (FCM) and parietal
osteoblasts (PCM), and tested it on the two cell types. As assessed
by BrdU incorporation, a significant mitogenic effect was exerted
by frontal cell-conditioned medium (FCM) on both frontal and
parietal osteoblasts (Figure 2C). Conversely, the parietal cell-
conditioned medium (PCM) did not elicit any mitogenic either on
FOb or POb cells. Moreover, the FCM enhanced osteogenic
differentiation of FOb and POb, and the effect was more dramatic
on POb as revealed by Alizarin red staining and its quantification
(Figure 2D).
Differential levels of biological FGF-2 protein between
primary cultures of neural crest derived frontal
osteoblasts and mesenchymal derived parietal
osteoblasts
FGF-2 is one of the well-known mitogens and widely reported to
be involved in osteogenesis. Indeed, it could also be one of the
factors contributing to the differences in proliferation and
osteogenesis observed between FOb and POb cells. Therefore,
to test this hypothesis we performed a western blotting analysis on
FOb and POb. Immunoblotting using anti-FGF-2 antibody
identified both high (HMW) and low molecular (LMW) weight
FGF-2 forms, and demonstrated clear differences between FOb
and POb cells (Figure 3). Significantly higher levels of FGF-2
proteins were detected in FOb cells compare to POb cells. This
trend was observed from embryonic stages through postnatal
day1, with highest difference in FGF-2 protein levels occurring in
E17.5 FOb cells.
The above results indicated that neural crest-derived FOb cells
expressed higher levels of both HMW and LMW FGF-2 forms.
This observation would strongly suggest that the FGF-2 could be
responsible for the strong mitogenic effect elicited by FCM (see
Figure 2C). To verify this hypothesis, we performed a cell
proliferation assay using FCM incubated with neutralizing anti-
FGF-2 antibody or FCM alone. For this purpose, FOb and POb
cells were cultured either in FCM or PCM for 24 hours and the
cell growth was measured by BrdU incorporation. Recombinant
human FGF-2 protein (rhFGF-2) at concentration of 20 ng/ml
was used as a positive control and normal irrelevant rabbit IgG as
a negative control. As illustrated in Figure 4, FCM alone induced
strong mitogenic activity on both FOb and POb cells, almost
similar to that elicited by rhFGF-2 (SF + FGF-2) stimulation, as
compared to serum-free medium control (SF). Incubation with
anti-FGF-2 antibody (FCM + Ab-FGF-2) inhibited significantly
the mitogenic activity of FMC. The inhibitory effect of
neutralizing anti-FGF-2 antibody was dose-dependent. In contrast,
PCM did not induce any mitogenic effect either on FOb or POb
cells, and no blocking effect by neutralizing antibody on PCM
(PCM + FGF-2 Neutralizing Ab) was observed. The latter
observation would suggest that there was no substantial amount
of FGF-2 present in PCM. Moreover, the irrelevant normal IgG
(FCM or PCM + IgG) did not show significant inhibitory activity
on the mitogenic effect of either FCM or PCM. Taken together,
these experiments suggested that the major mitogenic activity of
FOb cells and FCM was at least in part driven by FGF-2.
Differential activation of FGF signaling pathways
between neural crest derived frontal osteoblasts and
mesenchymal derived parietal osteoblasts
Thus, the above data revealed differential levels of FGF-2
protein between FOb and POb cells. This observation would
suggest that a differential endogenous activation of FGF signaling
pathways might also exist. Three FGF signaling transduction
pathways have been widely reported in the literatures: MAP
kinase, PI3K and PKC pathways [24,25,30]. To verify this
hypothesis we investigated the endogenous levels of phosphory-
lated FGF signaling proteins on FOb and POb cells by
immunoblotting analysis at early stage of osteogenesis
(Figure 5A–C). As illustrated in Figure 5A, FOb cells of
E17.5, E18.5 and P1 mice had significant higher levels of
phosphorylated ERK protein (p-ERK).
Similarly, for the PI3K signaling pathway, sharp differences
were observed between FOb and POb cells, with FOb cells
displaying significantly higher endogenous levels of phosphorylat-
ed Akt protein (p-Akt) (Figure 5B).
Finally, the endogenous levels of phosphorylated PKC a/b and
PKC d signaling proteins of PKC pathway was analyzed
(Figures 5C and D). Significantly higher levels of phosphorylat-
ed PKC a/b & PKC d proteins, were detected in FOb compared
to POb, at embryonic and postnatal stages.
Next, we investigated the effect of either exogenous added FGF-
2 protein or specific inhibitors of three FGF signaling pathways on
both FOb and POb cells (Figures 6A–D). Stimulation with
20 ng/ml of rhFGF-2 increased phosphorylation of ERK by two
folds in both FOb and POb cells (Figure 6A), whereas treatment
with UO126 an inhibitor of MAP kinase pathway inhibited the
effect of exogenous FGF-2, as well as, decreased the endogenous
activation of ERK protein in FOb and POb cells (Figure 6A).
Stimulation with rhFGF-2 induced a stronger activation of
PI3K, PKC a/b and d pathways in POb cells as compared to
FOb. Phosphorylated Akt, PKC a/b and d proteins were two fold
increased in POb cells as compared to FOb cells (Figures 6B–D).
In parallel, the FOb and POb cells undergoing FGF-2 induction
and their controls were also incubated with the two specific
inhibitors LY294002 and G06983 to block the signaling pathways.
The increased phosphorylation Akt, PKC a/b and d proteins
observed upon stimulation with exogenous rhFGF-2 was blocked
by specific inhibitors, the treatment also decreased the endogenous
Figure 1. Osteogenic and mitogenic potential of FOb and POb cells. A, alkaline phosphatase staining performed at day 7 of osteogenic
differentiation on frontal osteoblasts (FOb) and parietal osteoblasts (POb) harvested from embryonic 17.5 and 18.5 day (E17.5, E18.5) and post-natal
day (P1) mice. B, Alkaline phosphatase enzymatic activity. C, mineralization of extracellular matrix was assessed by Alizarin Red staining at day 21 day.
D, quantification of Alizarin red staining. Both alkaline phosphatase activity and mineralization of extra cellular matrix were more robust in FOb than
in POb, thus indicating the higher osteogenic capacity of the neural crest derived osteoblasts. E, quantitative real time PCR of osteogenic markers
Runx-2, Alk-Phos and Osteocalcin F, cell growth of E17.5, E18.5, and P1 FOb and POb cells was assessed by BrdU incorporation assay at 12 or 24 hours
in serum free medium cultures. G, cell growth investigated by immunoblotting analysis of proliferating cellular nuclear antigen (PCNA). Cell lysates
were collected after 24 hours culture in serum-free (SF) medium. a-tubulin was used as loading control. Histogram (bottom panel) represents the
densitometric analysis of the electrophoresis bands. H, long term growth curve assay performed by cell counting. The values are presented as means
6 SD of three independent experiments. BrdU incorporation, PCNA and growth curve assays showed statistical significant higher cell proliferation
capability in FOb as compared to POb. The results are presented as the mean 6 SD of three independent experiments. Asterisk * represent p,0.05.
doi:10.1371/journal.pone.0014033.g001
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d. Moreover, the inhibitors treatment decreased the proliferation
rate of both FOb and POb cells (Figure S1). Interestingly,
treatment with UO126 an inhibitor of MAP kinase pathway
decreased the proliferation rate of FOb cells to levels similar to
that of untreated POb cells (Figure S1).
Figure 2. Effects of interactions between FOb and POb cells on cell proliferation and osteoblast differentiation. A, BrdU incorporation
assay indicated that cell proliferation was significantly induced in POb cells when co-cultured with FOb cells. B, osteoblast differentiation of FOb and
POb co-cultures was investigated by Alizarin red staining and its quantification. Osteogenic differentiation of POb cells was significantly enhanced
when co-cultured with FOb cells, while co-cultures of FOb or POb cells with POb cells showed negative effects. Cells cultured alone were used as
controls. C, BrdU incorporation of FOb and POb cells cultured with FOb- and POb- derived conditioned media (FCM & PCM, serum free) revealed that
FMC significantly increased cell proliferation on both, FOb and POb cells at 24 hours. Serum free medium was used as control. D, osteogenic
differentiation of FOb and POb cells in presence of differentiation –FCM (dFMC) and differentiation-PCM (dPMC) supplemented with 3% FCS, was
measured and quantified by Alizarin Red staining. A greater osteogenic differentiation was observed in both FOb and POb cells only when incubated
with dFCM, but not with dPCM. Osteogenic differentiation medium supplemented with 3% FCS was used as control.
doi:10.1371/journal.pone.0014033.g002
FGF Signaling Calvarial Bones
PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e14033Knockdown of FGF Receptor 1 abolishes the greater
osteogenic potential of FOb cells, making them ‘‘POb
like’’
Taken together the above data strongly indicated that FOb cells
of neural crest origin were endowed with higher levels of FGF- 2
protein and endogenous activated FGF signaling compared to
POb cells of mesodermal origin. These observations would suggest
that activation of FGF signaling may play a crucial role in
conferring the greater osteogenic potential to FOb cells. To
determine the role of FGF signaling on the superior osteogenic
potential displayed by frontal bone we permanently knocked-down
FgfR1 in FOb cells harvested from E 17.5 mice. In addition, we
also compared the experimental and control FOb cells to
untreated E17.5 POb cells. RT-PCR and immunoblotting
analyses demonstrated that we could effectively knockdown the
Fgfr1 gene expression and the two FGFR1 isoform proteins (120
and 80 kDa) (Figures 7A and B). Osteogenic differentiation was
monitored at an intermediate time point (day 10) by measuring the
Alkaline phosphatase enzymatic activity. As shown in Figure 7C,
at day 10 of differentiation siFgfR1 osteoblasts displayed a
significantly decreased Alkaline phosphatase enzymatic activity
as compared to siRNA scramble FOb control cells. Interestingly,
the level of Alkaline phosphatase activity in siFgfR1 FOb cells
became similar to that of POb cells. Subsequently, mineralization
of extracellular matrix was assessed by Alizarin red staining at later
time point (day 21) with the progression of differentiation.
Quantification of Alizarin red staining revealed a significant
decrease in mineralization of extracellular matrix of siFgfR1 FOb
cells as compared to siRNA scramble FOb control cells
(Figure 7D). Thus, similarly to Alkaline phosphatase activity,
Alizarin red staining also demonstrated a significant impaired
osteogenic differentiation in siFgfR1 FOb cells. Moreover,
immunoblotting analysis of PCNA revealed decreased levels of
protein in siFgfR1 FOb cells, thus suggesting that downregulation
of FgfR1 effected also cell proliferation (data not shown).
Discussion
Differences in the embryonic origin of mammalian bones
composing the cranial vault have been well established [3]. While
the frontal bones of the calvarium are neural crest in origin, the
parietal bones arise from paraxial mesoderm. Our recent study
demonstrated that frontal bones of both juvenile and adult mice
are endowed with superior regenerative potential compared to
parietal bones, and furthermore, osteoblasts derived from either
juvenile or adult frontal bone display increased potential for
proliferation and osteogenic differentiation when compared to
osteoblasts obtained from the parietal bone [27]. Moreover,
another study profiling the gene expression pattern of major pro-
osteogenic FGF ligands and their receptors revealed substantial
differences in the expression of specific FGF ligands such as Fgf-2,
-9 and -18, as well as, receptors FgfR1-, R-2 and R-3, between
neural crest derived frontal bone relative to paraxial mesoderm
derived parietal bone [28]. Thus, the later study suggested that the
frontal bone might represent an activated FGF domain as
compared to parietal bone.
The current paper presents a follow up study addressing two
main questions: first, how far back can the differences observed
between frontal and parietal bones derived osteoblasts can be
traced? Is the greater osteogenic potential of frontal bone derived
osteoblasts a feature already detectable at embryonic stages or
restricted to postnatal stages? Second, is the frontal bone really a
domain with enhanced activation of FGF-signaling compared to
Figure 3. Identification of cellular FGF-2 proteins in neural crest derived FOb and mesenchymal derived POb cells. Endogenous levels
of FGF-2 were analyzed on FOb and POb cells by immunoblotting using antiFGF-2 antibody. Higher levels of high molecular weight (HMW) and low
molecular weight (LMW) FGF-2 forms were observed in FOb compared to POb at all stages analyzed. The total cellular FGF-2 proteins were quantified
by densitometry (lower panel), a-tubulin was used as loading control. Histogram represents the densitometric analysis of electrophoresis bands, the
relative intensities of bands were normalized to their respective loading control and set as 100% The results are presented as the mean 6 SD of three
independent experiments. The asterisks represent P value ,0.001.
doi:10.1371/journal.pone.0014033.g003
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demonstrated that indeed striking differences in proliferation and
osteogenic potential exist also between embryonic FOb and POb
cells. Our results demonstrated a higher cell proliferation capability
in neural crest derived osteoblasts compared to mesodermal
osteoblasts. The higher mitogenic ability of FOb was also parallel
by a greater potential for osteogenic differentiation.
To understand the molecular basis underlining the develop-
mental differences of FOb and POb cells, we investigated the effect
exerted by interactions between the two types of osteoblasts using
co-culture and conditioned media methods. The results obtained
from these experimental approaches demonstrated that FOb
exerted a positive influence on cell proliferation, as well as,
osteogenic differentiation, especially on POb cells, implicating that
neural crest osteoblasts might express some pro-osteogenic
molecules. Indeed, in agreement with what previously observed
at gene expression level, our analysis revealed that FOb
synthesized higher level of FGF-2 proteins and that the released
FGF-2 was responsible at least in part for the greater proliferation
rate of FOb. Of note, analysis for FGF-9 and FGF-18 proteins
revealed also higher levels of these molecules in FOb as compared
to POb cells (data not shown), thus further validating our previous
data obtained from the gene expression profiling [28].
To further reveal molecular/signaling differences between FOb
and POb cells in the context of FGF pathways, we investigated the
extent of endogenous activation of the three major FGF signaling
pathways, MAPK, PI3K, and PKC, in neural crest derived FOb and
mesoderm derived POb. The endogenous phosphorylation of the
signaling proteins were significantly higher in FOb than POb cells
Differences between FOb and POb cells were especially prominent
for the MAPK signaling pathway as indicated by more robust
phosphorylation of ERK proteins in FOb cells. This observation
supported the higher proliferative status of FOb cells compared to
POb cells, as the role of MAPK pathway is well established in
transducing the mitogenic activity elicited by FGF-2 [24,31,32].
Previous studies have linked PKC signaling pathways, especially
PKC a/b and d pathways to osteogenesis [25,33]. In our study,
the higher levels of phosphorylated PKC a/b and d proteins
Figure 4. Biological effect of exogenous FGF-2 on cell proliferation of FOb and POb cells. Cell proliferation of FOb and POb harvested
from E17.5 mice was measured by BrdU. Osteoblast cells were cultured with conditioned serum-free media collected from frontal osteoblasts (FCM)
or parietal osteoblasts (PCM) after 24 hours culture. The conditioned media were incubated with neutralizing anti-FGF-2 antibody at different
concentrations (1, 2 and 4 mg/ml). Same concentrations of irrelevant rabbit IgG were used as control. 20 ng/ml of hrFGF-2 was added to the medium
as a positive control (SF + FGF-2) and serum-free medium as a negative control (SF). FCM induced significant mitogenic effect, as much as the
exogenous added rhFGF-2, on both FOb and POB cells. Anti-FGF-2 antibody blocked the FGF-2 mitogenic effect in a dose-dependent manner.
Conversely PCM did not elicit mitogenic effect either on FOb or POb cells and there was no blocking effect by the FGF-2 neutralizing antibody on
PCM.
doi:10.1371/journal.pone.0014033.g004
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MAPK pathway was assessed by immmunoblotting using specific pERK antibody. Total ERK protein levels were analyzed using a pan-ERK antibody.
Significantly higher levels of pERK protein were detected in FOb cells compared to POb cells. B, phosphorylated Akt of PI3K pathway was determined
with pAkt antibody. Total Akt protein was analyzed with pan-Akt antibody. C, phosphorylated PKC a/b and D, PKC d of PKC pathway were
investigated by immunoblotting analyses using specific antibody against the phosphorylated proteins Total levels of PKC a/b and PKC d proteins
were detected using antibody against non-phosphorylated proteins. FOb cells displayed significantly higher endogenous activation of all three FGF
signaling pathways as compare to POb cells. Each membrane was stripped and subsequantially incubated with non-phosphorylated ERK, Akt, PKC a/
b, PKC d and a-tubulin antibody to assess for the total amount of endogenous proteinsand to control for equal loading and transfer of the samples.
Histograms represent the densitometric analysis of electrophoresis bands, the relative intensities of bands were normalized to their respective
loading control and set as 100% The results are presented as the mean 6 SD of three independent experiments. Asterisk * represents statistical
significance (*p,0.05).
doi:10.1371/journal.pone.0014033.g005
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their greater osteogenic potential. Thus, confirming the involve-
ment of FGF signaling in determining different osteogenic capacity
between FOb and POb cells.
Other interesting findings were found for the PI3K pathway.
Differences in the activation of signaling between FOb and POb
cells were the most prominent among the three FGF signaling
analyzed. Protein kinase B (PKB/Akt), a serine-threonine protein
kinase and a downstream target of PI3K signaling pathway, has
long been implicated in cell cycle progression, programmed cell
death and cell survival [34,35]. More recently, it has also been
reported playing a crucial role in stem cell renewal [36].
Taking together, highly activated PI3K intracellular pathway
with enhanced Akt phosphorylation activity may well reflect an
increase in cell survival rate and cell renewal ability of neural crest
derived FOb, indicating more progenitors entering the osteogenic
differentiation pathway and less entering the apoptotic pathway
within the frontal bone as compared to mesoderm derived parietal
Figure 6. FGF-2 induction of the intracellular FGF signaling pathways on FOb and POb cells. FOb and POb cells harvested from E17.5
mice were cultured in serum free a-MEM for 12 hours in presence of specific inhibitors of the FGF signaling pathways to pre-empty endogenous FGF-
2 activity. Then cells were treated with 20 ng/ml of rhFGF-2. A, effect of exogenous FGF-2 and inhibitors of MAPK signaling pathway. FGF-2
stimulation for 30 minutes increased phosphorylation of ERK protein equally in FOb and POb cells. Co-treatment with 10 mM U0126 inhibitor
inhibited the FGF-2 induction as well as the endogenous phosphorylation of pERK protein in untreated FGF-2 FOb and POb cells. Histogram
represents densitometric analysis of electrophoresis bands as above. B, effect of exogenous FGF-2 and inhibitors of PI3K signaling pathway. FGF-2
treatment resulted in increased pAkt phosphorylation which was two fold higher in POb cells compared to FOb cells. Treatment with 20 mM
LY294002 inhibitor mostly abrogated the effect of exogenous FGF-2 and drastically reduced the endogenous level of pAkt protein in untreated FGF-2
FOb cells. Histogram represents densitometric analysis of electrophoresis bands. C, effect of exogenous FGF-2 and inhibitors of PKC a/b signaling
pathway. FGF-2 treatment also induced an increased phosphorylation of PKC a/b proteins which was inhibited by co-treatment with 2 mMG O ¨6983
inhibitor. Treatment with the inhibitor also reduced the endogenous level of p PKC a/b proteins in untreated FGF-2 cells. Histogram represents
densitometric analysis of electrophoresis bands. D, effect of exogenous FGF-2 and inhibitors of PKC d signaling pathway. FGF-2 and/or inhibitor
treatments on PKC d protein produced a similar effect to that observed on PKC a/b proteins. Asterisk * represents statistical significance (*p,0.05).
doi:10.1371/journal.pone.0014033.g006
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capacity of neural crest derived frontal bone compared to the
mesoderm derived parietal bone [27]. The neural crest cells have
been described as progenitor cells with higher cell renewal ability
[37]. This may be one of the key features that differentiate neural
crest osteoblasts from the mesenchymal osteoblasts. Our study
revealed that differences between FOb and POb cells were more
prominent at embryonic stages than early postnatal day 1. We
have also observed that at later postnatal stages (P30 and P60),
differences between FOb and POb cells in PI3K activation
decreased, indicating that aging is also an important factor in
controlling mitogenic and osteogenic potential of osteoblasts.
One of the interesting findings that emerged from this study was
the inducible osteogenic potential of POb cells observed upon
FGF-2 treatment. Addition of exogenous FGF-2 protein to POb
cells made them ‘‘FOb-like’’. Conversely downregulation of FgfR1
in FOb cells impaired their osteogenic potential, mimicking POb
cells. That opens the possibility to increase the proliferation and
osteogenic potential of POb to that of FOb merely by treatment
with exogenous growth factors or cytokines, (e.g. members of FGF
family). Our results also suggested that the PI3K, PKC a/b and d
pathways might be more important for enhancing the plasticity of
the mesenchymal parietal cells towards osteogenic differentiation.
In addition, PI3K, PKC a/b and d pathways might be more
Figure 7. Silencing of FGF Receptor 1 abrogates the greater osteogenic potential of FOb cells. A, RT-PC analysis demonstrating a
decrease in fgfr1 gene expression by siRNA. Densitometry analysis of RT-PCR (Panel below), bands were scanned and quantified using Image J 1.36b
software (NIH). B, Western blot demonstrating decreased levels of 2 different FGFR1 isoforms (80 kDa and 122 kDa) in siFgfR1 transduced FOb cells.
The intensity of the bands were quantified as above (Panels below). *p,0.05. C, Alkaline phosphatase enzymatic activity of siFgfR1 FOb cells
demonstrating that frontal bone derived osteoblasts transduced with siFgfR1 lost their greater osteogenic potential and became more POb-like. D,
Alizarin red staining showing marked decreased of mineralization of extracellular matrix in siFgfR1 FOb cells. E, Quantification of Alizarin Red. A
lentivirus siRNA scramble was used as control.
doi:10.1371/journal.pone.0014033.g007
FGF Signaling Calvarial Bones
PLoS ONE | www.plosone.org 12 November 2010 | Volume 5 | Issue 11 | e14033important for enhancing the plasticity of the mesenchymal POb
cells towards osteogenic differentiation. Further exploration the
molecular mechanisms and the interactions between the intracel-
lular signaling pathways in neural crest derived osteoblasts would
lead to the understanding of the osteogenesis in developing
calvaria and the prospects of improving the differentiation stage-
dependent mitogenesis and osteogenic differentiation in mesen-
chymal osteoblasts and aged osteoblasts.
We have recently reported, that the canonical Wnt-pathway has
also an important role in determining the different osteogenic
potential and healing capacity of frontal and parietal bones [27].
Moreover, FGF-2 treatment induces phosphorylation of GSK-3b
and increases the nuclear levels of b-catenin in osteoblasts
suggesting that enhanced activation of Wnt signaling might be
mediated by FGF [27]. Thus, the data suggest that in frontal bone
a cross-talk between FGF and canonical Wnt-signaling exists. In
the light of our current and previous study we propose that FGF-
ligands not only exert direct effects on osteoprogenitor cells but,
may also have indirect effects by activating the canonical Wnt-
signaling, during osteogenesis and/or bone regeneration.
Obtaining a comprehensive understanding of unique cell
biology of calvarial osteoblasts from dissimilar embryonic origins,
and understanding how those differences translate into variable
potential strategies for endogenous bone regeneration, is critical to
the optimization of cell-based skeletal tissue repair modalities.
Supporting Information
Figure S1 Growth curve assay performed as described under
Material and Methods section, on cells maintained in growth
medium supplemented with or without the following inhibitors:
5 mM U-0126, 10 mM LY-294002 and 1 mMG O ¨ -6983. Control
cells were maintained in growth medium containing 0.1%DMSO.
The values are presented as means 6 SD of three independent
experiments.
Found at: doi:10.1371/journal.pone.0014033.s001 (6.62 MB TIF)
Author Contributions
Conceived and designed the experiments: SL NQ. Performed the
experiments: SL. Analyzed the data: SL NQ MTL. Contributed
reagents/materials/analysis tools: SL NQ. Wrote the paper: SL NQ.
References
1. Morriss-Kay GM (2001) Derivation of the mammalian skull vault. J Anat 199(Pt
1–2): 143–151.
2. Chai Y, Jiang X, Ito Y, Bringas P, Jr., Han J, et al. (2000) Fate of the
mammalian cranial neural crest during tooth and mandibular morphogenesis.
Development 127(8): 1671–1679.
3. Jiang X, Iseki S, Maxson RE, Sucov HM, Morriss-Kay GM (2002) Tissue
origins and interactions in the mammalian skull vault. Dev Biol 241(1): 106–116.
4. LaBonne C, Bronner-Fraser M (1999) Molecular mechanisms of neural crest
formation. Annu Rev Cell Dev Biol 15: 81–112.
5. Anderson DJ (2000) Genes, lineages and the neural crest: a speculative review.
Philos Trans R Soc Lond B Biol Sci 355(1399): 953–964.
6. Trainor P, Krumlauf R (2002) Development. Riding the crest of the Wnt
signaling wave. Science 297(5582): 781–783.
7. Couly G, Grapin-Botton A, Coltey P, Le Douarin NM (1996) The regeneration
of the cephalic neural crest, a problem revisited: the regenerating cells originate
from the contralateral or from the anterior and posterior neural fold.
Development 122(11): 3393–3407.
8. Kontges G, Lumsden A (1996) Rhombencephalic neural crest segmentation is
preserved throughout craniofacial ontogeny. Development 122(10): 3229–3242.
9. Le Douarin NM, Calloni GW, Dupin E (2008) The stem cells of the neural crest.
Cell Cycle 7(8): 1013–1019.
10. Karsenty G (2001) Minireview: transcriptional control of osteoblast differenti-
ation. Endocrinology 142(7): 2731–2733.
11. Karsenty G, Wagner EF (2002) Reaching a genetic and molecular understand-
ing of skeletal development. Dev Cell 2(4): 389–406.
12. Karsenty G (2008) Transcriptional control of skeletogenesis. Annu Rev
Genomics Hum Genet 9: 183–196.
13. Muenke M, Schell U (1995) Fibroblast-growth-factor receptor mutations in
human skeletal disorders. Trends Genet 11(8): 308–313.
14. Naski MC, Ornitz DM (1998) FGF signaling in skeletal development. Front
Biosci 3: d781–794.
15. Ornitz DM, Itoh N (2001) Fibroblast growth factors. Genome Biol 2(3):
REVIEWS3005.
16. Marie PJ (2003) Fibroblast growth factor signaling controlling osteoblast
differentiation. Gene 316: 23–32.
17. Mansukhani A, Bellosta P, Sahni M, Basilico C (2000) Signaling by fibroblast
growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating
mutations blocks mineralization and induces apoptosis in osteoblasts. J Cell Biol
149(6): 1297–1308.
18. Cowan CM, Quarto N, Warren SM, Salim A, Longaker MT (2003) Age-related
changes in the biomolecular mechanisms of calvarial osteoblast biology affect
fibroblast growth factor-2 signaling and osteogenesis. J Biol Chem 278(34):
32005–32013.
19. Fakhry A, Ratisoontorn C, Vedhachalam C, Salhab I, Koyama E, et al. (2005)
Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-
dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and
enhancement of osteogenic potential. Bone 36(2): 254–266.
20. Quarto N, Longaker MT (2006) FGF-2 inhibits osteogenesis in mouse adipose
tissue-derived stromal cells and sustains their proliferative and osteogenic
potential state. Tissue Eng 12(6): 1405–1418.
21. Dailey L, Ambrosetti D, Mansukhani A, Basilico C (2005) Mechanisms
underlying differential responses to FGF signaling. Cytokine Growth Factor
Rev 16(2): 233–247.
22. Jackson RA, Nurcombe V, Cool SM (2006) Coordinated fibroblast growth
factor and heparan sulfate regulation of osteogenesis. Gene 379: 79–91.
23. Deng ZL, Sharff KA, Tang N, Song WX, Luo J, et al. (2008) Regulation of
osteogenic differentiation during skeletal development. Front Biosci 13:
2001–2021.
24. Chaudhary LR, Avioli LV (1997) Activation of extracellular signal-regulated
kinases 1 and 2 (ERK1 and ERK2) by FGF-2 and PDGF-BB in normal human
osteoblastic and bone marrow stromal cells: differences in mobility and in-gel
renaturation of ERK1 in human, rat, and mouse osteoblastic cells. Biochem
Biophys Res Commun 238(1): 134–139.
25. Kim HJ, Kim JH, Bae SC, Choi JY, Kim HJ, et al. (2003) The protein kinase C
pathway plays a central role in the fibroblast growth factor-stimulated expression
and transactivation activity of Runx2. J Biol Chem 278(1): 319–326.
26. Chaudhary LR, Hofmeister AM, Hruska KA (2004) Differential growth factor
control of bone formation through osteoprogenitor differentiation. Bone 34(3):
402–411.
27. Quarto N, Wan DC, Kwan MD, Panetta NJ, Li S, et al. (2009) Origin Matters:
Differences in Embryonic Tissue Origin and Wnt Signaling Determine the
Osteogenic Potential and Healing Capacity of Frontal and Parietal Calvarial
Bones. J Bone Miner Res 25(7): 1680–1694.
28. Quarto N, Behr B, Li S, Longaker MT (2009) Differential FGF ligands and FGF
receptors expression pattern in frontal and parietal calvarial bones. Cells Tissues
Organs 190(3): 158–169.
29. Quarto N, Wan DC, Longaker MT (2008) Molecular mechanisms of FGF-2
inhibitory activity in the osteogenic context of mouse adipose-derived stem cells
(mASCs). Bone 42(6): 1040–1052.
30. Debiais F, Lefevre G, Lemonnier J, Le Mee S, Lasmoles F, et al. (2004)
Fibroblast growth factor-2 induces osteoblast survival through a phosphatidy-
linositol 3-kinase-dependent, -beta-catenin-independent signaling pathway. Exp
Cell Res 297(1): 235–246.
31. Ornitz DM, Marie PJ (2002) FGF signaling pathways in endochondral and
intramembranous bone development and human genetic disease. Genes Dev
16(12): 1446–1465.
32. Li S, Quarto N, Longaker MT (2007) Dura mater-derived FGF-2 mediates
mitogenic signaling in calvarial osteoblasts. Am J Physiol Cell Physiol 293(6):
C1834–1842.
33. Yang D, Guo J, Divieti P, Bringhurst FR (2006) Parathyroid hormone activates
PKC-delta and regulates osteoblastic differentiation via a PLC-independent
pathway. Bone 38(4): 485–496.
34. Sandeep Robert Datta SR, et al. (1999) Cellular survival: a play in three Akts.
Genes & Development 13: 2905–2927.
35. Chaudhary LR, Hruska KA (2001) The cell survival signal Akt is differentially
activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells. J Cell Biochem
81(2): 304–311.
36. Paling NR, Wheadon H, Bone HK, Welham MJ (2004) Regulation of
embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent
signaling. J Biol Chem 279(46): 48063–48070.
37. Trentin A, Glavieux-Pardanaud C, Le Douarin NM, Dupin E (2004) Self-
renewal capacity is a widespread property of various types of neural crest
precursor cells. Proc Natl Acad Sci U S A 101(13): 4495–4500.
FGF Signaling Calvarial Bones
PLoS ONE | www.plosone.org 13 November 2010 | Volume 5 | Issue 11 | e14033